Funded Tech Companies

AusperBio

Researching who provided funding to AusperBio? CDH Investments, Hankang Capital and Genesis Capital Growth joined the equity holders in this life sciences company.

Company Overview

Contact Information

Company Background Information

Overview

AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging our innovative and proprietary Med-Oligo� ASO platform with effective targeted delivery technologies, we strive to unleash the power of ASO therapeutics to treat a wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, and to transform patient lives.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/29/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Guofeng Cheng

        

Chief Operating Officer

Suyun Xu

        

Chief Scientific Officer

Chris Yang

        

Vice President

Hengxu Wei

        

VP - Bus. Development

Miao Wang

        

VP - Bus. Development

Xuetao Wen

        

VP - R & D

Yang Tian

        

Company Investors

• CDH Investments
• Hankang Capital
• Genesis Capital Growth
• Qiming Venture Partners USA
• Sherpa Capital
• Yuanbio Venture Capital
• InnoPinnacle Fund

Browse more funded tech companies:

Aushon BioSystems | Auspex Pharmaceuticals

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary